Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bodhi Tree Biotechnology (BDTB) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q3 2025 value amounting to 89.06%.

  • Bodhi Tree Biotechnology's EBIT Margin changed N/A to 89.06% in Q3 2025 from the same period last year, while for Dec 2025 it was 1131.58%, marking a year-over-year change of. This contributed to the annual value of 868.34% for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Bodhi Tree Biotechnology's EBIT Margin is 89.06%.
  • Bodhi Tree Biotechnology's 5-year EBIT Margin high stood at 89.06% for Q3 2025, and its period low was 1295.54% during Q4 2024.